Mechanical Insufflation-exsufflation and Hypertonic Saline in Nosocomial Bacterial Respiratory Tract Infection
Key facts
- Who runs it
- Hospital San Carlos, Madrid
- Where
- Spain7 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 100 people, planned
- Started
- 1 Jan 2026
- Expected to end
- 30 Dec 2027
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Mechanical insufflation-exsufflation
- Standard of Care
- Hypertonic saline with hyaluronic acid
- Record updated
- 26 March 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Signed informed consent
- Nosocomial pneumonia (vHAP or VAP) or nosocomial tracheobronchitis
- Intubated with a cuffed endotracheal tube or tracheostomy cannula
Who cannot take part
- Bronchospasm (patients on bronchodilators for previous bronchospasm may be included
- Suspected unmonitored intracraneal hypertension
- Ominous prognosis
- Frank hemoptisis
- Barotrauma (pneumothorax or pneumomediastinum)
- Unstable thoracic cage
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Multicenter, randomized open label clinical trial to evaluate IEM and HS as concomitant therapy for respiratory tract infection in patients under artificial ventilation in the ICU.
Read full original descriptionShow less
Lung infection is a serious complication that may occur during hospital stay and may need artificial respiration or even develop during artificial ventilation for other causes.
Current specific treatment consists of intravenous antibiotics. The current study evaluated whether aspiration and drainage of infected sputum helps curing this severe complication and whether nebulized HS has additional benefits, like loosening of secretions, eradicating bacteria or reducing inflammation.
The 3 groups in the trial
- Standard of CareExisting treatment, for comparison
Standard of care: Systemic antibiotic therapy according to local protocol and at the discretion of the attending intensivist.
- Mechanical insufflation-exsufflation with hypertonic saline/hyaluronic acid cominationTreatment being tested
Systemic antibiotic therapy choice according to local protocol and at the discretion of the attending intensivist plus Mechanical insufflation-exsufflation (MI-E sessión tid during the first 48 hours, followed by MI-E if secretions are present or suspected; recommended settings +50 cmH2O/-50 cmH2O) with simultaneous nebulization of hypertonic saline (7%) with hyaluronic acid (0.1%).
Treatment: Mechanical insufflation-exsufflation and Hypertonic saline with hyaluronic acid
- Mechanical insufflation-exsufflationTreatment being tested
Systemic antibiotic therapy choice according to local protocol and at the discretion of the attending intensivist plus Mechanical insufflation-exsufflation (MI-E sessión tid during the first 48 hours, followed by MI-E if secretions are present or suspected; recommended settings +50 cmH2O/-50 cmH2O)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Aspiration of Bronchial Secretions With Mechanical Insufflation-Exsufflation and Hypertonic Saline in Bacterial Nosocomial Tracheobronchitis and Pneumonia in Intubated Patients.
- Record updated
- 26 March 2025